New in Regulation and Policy

Does the industry need to rethink its approach to regulatory approval in light of low approval rates?

2 May 2013 / By Tim / Featured on App, Regulation and Policy, Reports / 0 comments

Download the eBook here >> We asked several industry experts at the World Vaccine Congress USA 2013 the following three questions: What role do you [...]

 

More in Regulation and Policy

• 

  Pandemrix and Bexsero among 100+ drugs that must display EMA ‘black triangle’

  26 April 2013 / By Tim / Featured on App, Regulation and Policy / 0 comments

   
• 

  Sanofi’s hexavalent paediatric vaccine gets EU marketing approval

  24 April 2013 / By Tim / Featured on App, Regulation and Policy / 0 comments

   
• 

  Biodefense vaccines– overview, stockpiling and regulation

  23 April 2013 / By Tim / Events, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines / 0 comments

   
• 

  Global Immunization Strategies and Initiatives

  17 April 2013 / By Tim / Events, Featured on App, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines / 0 comments

   
• 

  GlaxoSmithKline’s quadrivalent influenza vaccine approved in UK and Germany

  4 April 2013 / By Tim / Featured on App, Flu, Prophylactic Vaccines, Regulation and Policy / 0 comments

   
• 

  Guest bloggers for World Vaccine Congress Washington 2013

  26 March 2013 / By Freya Smale / Emerging Markets, Featured on App, Flu, Partnering and Corporate strategy, Prophylactic Vaccines, R&D, Regulation and Policy, Therapeutic Vaccines, Veterinary Vaccines / 0 comments

   
• 

  Is it ethical to test the anthrax vaccine in children?

  20 March 2013 / By Tim / Featured on App, Prophylactic Vaccines, Regulation and Policy / 2 comments

   
• 

  GHTC report warns against R&D cuts in US

  28 February 2013 / By Tim / Featured on App, R&D, Regulation and Policy / 0 comments

   
• 

  Quantitative Biology a system approach to vaccines

  22 February 2013 / By Freya Smale / Regulation and Policy / 0 comments

   
• 

  Risk perception, vaccine hesitancy and behaviour

  20 February 2013 / By Freya Smale / Regulation and Policy / 0 comments